$NXTC 8-K SEC Filings

Filed On	Filing
25 Sep 2026	8-K: Other Events Petitioner NextCure, Inc. (“NextCure” or the “Company”), by and through its undersigned counsel, brings this petition pursuant to 8 Del. C. § 205, seeking to have this Court validate a potentially defective corporate act as follows:
03 Sep 2026	8-K: Entry into a Material Definitive Agreement
06 Aug 2026	8-K: Results of Operations and Financial Condition
14 Jul 2026	8-K: Entry into a Material Definitive Agreement; Costs Associated with Exit or Disposal Activities +4 more
25 Jun 2026	8-K: Departure/Election of Directors or Officers; Compensation; Submission of Matters to a Vote of Security Holders
01 Jun 2026	8-K: Regulation FD Disclosure; Other Events
07 May 2026	8-K: Results of Operations and Financial Condition
05 Mar 2026	8-K: Results of Operations and Financial Condition
23 Jan 2026	8-K: Results of Operations and Financial Condition; Regulation FD Disclosure +1 more
19 Dec 2025	8-K: Other Events
17 Nov 2025	8-K: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities +2 more
05 Nov 2025	8-K: Results of Operations and Financial Condition
25 Aug 2025	8-K: Departure/Election of Directors or Officers; Compensation
07 Aug 2025	8-K: Results of Operations and Financial Condition
14 Jul 2025	8-K: Material Modification to Rights of Security Holders; Amendments to Articles/Bylaws; Change in Fiscal Year
10 Jul 2025	8-K: Other Events
23 Jun 2025	8-K: Submission of Matters to a Vote of Security Holders
16 Jun 2025	8-K: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities +2 more
01 May 2025	8-K: Results of Operations and Financial Condition
10 Apr 2025	8-K: Regulation FD Disclosure

Comments